Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.770
-0.150 (-7.81%)
May 15, 2026, 4:00 PM EDT - Market closed
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $75.76 million as of May 18, 2026. Its market cap has increased by 81.67% in one year.
Market Cap
75.76M
Enterprise Value
-19.56M
1-Year Change
81.67%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $75.76M, a decrease of -67.78%. That is a compound annual growth rate of -27.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 75.76M | -0.38% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 80.06M |
| Gossamer Bio | 79.80M |
| OS Therapies | 79.03M |
| MAIA Biotechnology | 76.45M |
| Rallybio | 75.64M |
| XBiotech | 75.00M |
| Cue Biopharma | 74.91M |
| PDS Biotechnology | 74.79M |